About Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
10
Genentech, Inc.
1
Clinical Trials at Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu
During the past decade, Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
2006-06-26
2014-09-22
Completed
417
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection
2015-10-05
2022-06-14
Completed
809
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
2016-06-30
2023-06-30
Active, not recruiting
1,214
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
2017-01-03
2022-12-08
Completed
778
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu"
#1 collaborator was "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu
According to Clinical.Site data, the most researched conditions in "Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu" are
"Breast Cancer" (2 trials), "Urothelial Carcinoma" (2 trials), "Bladder Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Renal Cell" (1 trials). Many other conditions were trialed in "Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu" in a lesser frequency.
Clinical Trials Intervention Types at Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu
Most popular intervention types in "Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu" are "Drug" (11 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (6 trials), "Placebo" (4 trials), "Docetaxel" (3 trials), "Herceptin" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu
The vast majority of trials in "Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu" are
10 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu
Currently, there are NaN active trials in "Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".